Downstream processing of oncoretroviral and lentiviral gene therapy vectors.
about
Production of lentiviral vectorsEfficient human hematopoietic cell transduction using RD114- and GALV-pseudotyped retroviral vectors produced in suspension and serum-free media.Highly efficient concentration of lenti- and retroviral vector preparations by membrane adsorbers and ultrafiltration.Simplified production and concentration of HIV-1-based lentiviral vectors using HYPERFlask vessels and anion exchange membrane chromatography.Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfectionProlonged survival and phenotypic correction of Akp2(-/-) hypophosphatasia mice by lentiviral gene therapy.Retroviral particles are effectively purified on an affinity matrix containing peptides selected by phage-display.Recent advances in lentiviral vector development and applications.Retroviral vectors for gene therapy.Downstream processing of cell culture-derived virus particles.New developments in lentiviral vector design, production and purification.Stability of Retroviral Vectors Against Ultracentrifugation Is Determined by the Viral Internal Core and Envelope Proteins Used for Pseudotyping.COS-1 cells as packaging host for production of lentiviruses.Stability, biophysical properties and effect of ultracentrifugation and diafiltration on measles virus and mumps virus.Streamlined design of a self-inactivating feline immunodeficiency virus vector for transducing ex vivo dendritic cells and T lymphocytes.Sustained, localized transgene expression mediated from lentivirus-loaded biodegradable polyester elastomers.Optimization of lentiviral vector production using polyethylenimine-mediated transfection.Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction.
P2860
Q26750586-F0E2E891-0208-4DA1-8CE5-F62CC57861A6Q30479723-980DD5AA-BDE0-4F64-B707-7E42A9ADDC4FQ31014077-753D2EF9-50AB-40F4-8666-5A744BB77D5EQ33409769-B9EE14AE-4524-4BE3-9DD2-A889169DDEEFQ34204409-D9523B88-DFC3-4202-8FE4-0861D8739298Q35229937-11B10AF0-928F-4D0F-9D9C-F6638F46E5C3Q36095367-D682A698-DAC7-4915-89F3-7051CB4E307FQ37678176-4B537CAA-8F1B-405E-B2A3-88507C48F9C8Q37809064-2338D405-1EEC-466A-97C0-DFC5F6790488Q37944322-117DD4DD-C68F-4DCA-9EC4-C366F08AA687Q38099382-CFC5E923-BBD9-446E-BAB6-4865396A2A71Q39324840-4A71E7F3-757D-4900-8CDB-E5D9B4E3C4E4Q39576647-0C97C196-9AD2-4E16-BD70-737F3E6E0D47Q39952994-B405268C-0922-4CCE-80FD-E2A1AAE193C1Q40016567-4CDDC8EC-A33C-4E6C-BD72-81D2C259C6D5Q40740910-7A86E094-CB2C-4130-9C2F-3219BD6E497EQ42179880-0E0FE76D-B5BE-40EE-B64F-BA92811D3CC0Q50282696-43822201-B68E-4BCE-AF0E-688F8731D00B
P2860
Downstream processing of oncoretroviral and lentiviral gene therapy vectors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Downstream processing of oncoretroviral and lentiviral gene therapy vectors.
@ast
Downstream processing of oncoretroviral and lentiviral gene therapy vectors.
@en
type
label
Downstream processing of oncoretroviral and lentiviral gene therapy vectors.
@ast
Downstream processing of oncoretroviral and lentiviral gene therapy vectors.
@en
prefLabel
Downstream processing of oncoretroviral and lentiviral gene therapy vectors.
@ast
Downstream processing of oncoretroviral and lentiviral gene therapy vectors.
@en
P2093
P1476
Downstream processing of oncoretroviral and lentiviral gene therapy vectors.
@en
P2093
Alain Garnier
Amine Kamen
María de Las Mercedes Segura
P304
P356
10.1016/J.BIOTECHADV.2005.12.001
P577
2006-01-30T00:00:00Z